)
US Physical Therapy (USPH) investor relations material
US Physical Therapy 18th Annual Southwest IDEAS Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business model and footprint
Operates in 45 states with ~800 locations across ~150 locally branded partnerships; ownership is majority-held, with local partners typically holding 30%-35%.
Serves a fragmented ~$56B outpatient orthopedic PT market; favorable demographics and 27 consecutive months of record visits per clinic per day support demand.
Selected acquisitions are typically majority stakes, immediately accretive and priced at a blended ~7.25x-7.5x EBITDA; historical multiples ranged from 5x to 10x.
Hospital affiliations and reimbursement
NYU and a Gulf Coast hospital are the first two affiliations; all 62 New York-area clinics are now enrolled, with plans to add more and exclusive 10-year agreements expected to continue into perpetuity.
Hospital programs contributed less than 5% of total revenue in Q2 and 13% of PT revenue in Q3; management expects a higher contribution in Q4.
New York is expected to deliver 650,000+ visits by year-end; higher reimbursement lifted net rate per visit $5 YoY, to $111+ in Q3 and $112 in September, both record levels.
Roughly a dozen markets are under discussion, with several affiliations expected to launch in the coming period; start-up investment is limited, while hospital timelines are the main pacing factor.
Industrial injury prevention
Onsite trainers and therapists serve large self-insured employers under evergreen one-year contracts; clients are told to expect a 3x return in hard-cost savings.
Built from a small 2017 acquisition, the segment now generates 15% of revenue, or $130M-$140M annually, with strong organic growth and margins.
- PT volume and hospital affiliations lifted Q3 revenue and adjusted EBITDA despite cost pressure.USPH
Q3 2026 - Exclusive NYU Langone partnership and robust acquisitions drive growth and margin expansion.USPH
17th Annual Midwest IDEAS Conference - Q2 2026 revenue up 8.5% year-over-year; net income fell, but EBITDA guidance reaffirmed.USPH
Q2 2026 - Strong organic and acquisition-driven growth, with Medicare rate tailwinds and expanding high-margin segments.USPH
The 15th Annual East Coast IDEAS Conference - Q1 2026 revenue up 7.9% to $198.3M; EBITDA guidance reaffirmed; net income declined.USPH
Q1 2026 - Proxy seeks approval for directors, executive pay, auditor, and highlights governance and ESG.USPH
Proxy filing - Q3 2024 delivered record patient volumes, 12% revenue growth, and major portfolio optimization.USPH
Q3 2024 - Record patient volumes and revenue growth, but net income and margins pressured by labor costs.USPH
Q2 2024 - Record Q1 patient volume, 18.1% revenue, and 23% net income growth, fueled by acquisitions.USPH
Q1 2025
)
)
)
)
)
)
)
)